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Abstract 
Objective 
To characterize outer retinal structure in Best Vitelliform Macular 
Dystrophy (BVMD), using spectral domain optical coherence 
tomography (SD-OCT) and adaptive optics scanning light 
ophthalmoscopy (AOSLO). 
Methods 
Four symptomatic members of a family with BVMD with known 
BEST1 gene mutation were recruited. Thickness of two outer retinal 
layers corresponding to photoreceptor inner and outer segments were 
measured using SD-OCT. Photoreceptor mosaic AOSLO images within 
and around visible lesions were obtained, and cone density was 
assessed in two subjects. 
Results 
Each subject was at a different stage of BVMD, with 
photoreceptor disruption evident by AOSLO at all stages. When 
comparing SD-OCT and AOSLO images from the same location, AOSLO 
images allowed for direct assessment of photoreceptor structure. A 
variable degree of retained photoreceptors was seen within all lesions. 
The photoreceptor mosaic immediately adjacent to visible lesions 
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appeared contiguous and was of normal density. Fine hyperreflective 
structures were visualized by AOSLO, and their anatomical orientation 
and size are consistent with Henle fibers. 
Conclusions 
AOSLO findings indicate substantial photoreceptor structure 
persists within active lesions, accounting for good visual acuity in 
these patients. Despite previous reports of diffuse photoreceptor outer 
segment abnormalities in BVMD, our data reveal normal photoreceptor 
structure in areas adjacent to clinical lesions. 
Clinical Relevance 
This study demonstrates the utility of AOSLO for understanding 
the spectrum of cellular changes that occur in inherited degenerations 
such as BVMD. Photoreceptors are often significantly affected at 
various stages of inherited degenerations, and these changes may not 
be readily apparent with current clinical imaging instrumentation. 
Best Vitelliform Macular Dystrophy (BVMD), also known as 
Vitelliform Macular Dystrophy type 2 or Best’s Disease (OMIM # 
607854; BEST1)is an autosomal dominant form of macular 
degeneration of variable penetrance characterized by varying 
accumulation of yellowish vitelliform material in the macula.1,2 Affected 
individuals also show a reduction in the electrooculogram (EOG) light 
peak but a normal full-field electroretinogram (ERG).1,3 Mutations in 
the BEST1 gene on chromosome 11q13 encoding bestrophin-1 cause 
BVMD.4–6 Bestrophin-1 is an integral membrane protein that has been 
localized to the basolateral membrane of the retinal pigment 
epithelium (RPE)7 and is thought to be a Ca+2 sensitive Cl− channel 
protein or influences the regulation of Ca+2 channels.8 
The clinical appearance of BVMD varies by the stage of the 
disease.2 Initially, retinal fundi may appear normal (previtelliform). 
Characteristically, there is development of macular fluid- and debris-
filled retinal detachments forming a yellow yolk-like or vitelliform 
lesion or lesions. With time, the vitelliform material may become more 
heterogenous with various layers (pseudohypopyon) and may appear 
to dissolve, leaving isolated clumps of material at the edges of the 
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lesion (vitelliruptive). Eventually localized atrophy and fibrosis 
develops in the location of the vitelliform lesion.2 Despite presence of 
vitelliform lesion(s), vision is usually good in earlier stages of the 
disease, visual acuity of 20/40 or better vision being reported in 76% 
of individuals less than 40 years of age.9 It has been shown that 
normal acuity can be maintained in individuals having substantial 
photoreceptor degeneration.10,11 Thus, the good visual acuity in 
patients with BVMD does not necessarily inform about the degree of 
photoreceptor degeneration. 
Histopathologic findings from BVMD donor eyes are limited but 
demonstrate abnormal accumulation of lipofuscin granules in the 
RPE12–15 and photoreceptor degeneration over areas of intact RPE.16,17 
Recently a knock-in mouse model of BVMD showed increased 
accumulation of lipofuscin in the RPE and deposition of subretinal 
debris composed of unphagocytosed photoreceptor outer segments 
and lipofuscin granules.18 It is hypothesized that impairment (rather 
than loss) of RPE to fully degrade phagocytosed outer segments leads 
to photoreceptor degeneration in BVMD, either alteration of the ionic 
milieu of the subretinal space due to bestrophin mistargeting or loss of 
cell-to-cell contact.13,16 
Optical coherence tomography (OCT) imaging techniques allow 
for non-invasive assessment of retinal structure, and numerous studies 
have utilized this imaging approach to assess outer retinal structure in 
BVMD.19–23 OCT imaging has shown that the characteristic vitelliform 
lesions of BVMD are the result of accumulation of material in the 
subretinal space above the RPE and below the outer segments of the 
photoreceptors.20,21,24,25 Also, despite bestrophin–1 being localized to 
the RPE, OCT has shown significant changes to outer retinal structure 
are evident at various stages of the disease, and it has been suggested 
that thickening of the reflective layer corresponding to the 
photoreceptors may be one of the earliest anatomical changes visible 
by OCT with BVMD.20,21,26 However, examples exist where the 
resolution of existing OCT technology is not sensitive enough to detect 
pronounced photoreceptor disruption.27–29 Thus, despite the OCT 
findings in BVMD, the nature of photoreceptor structure in BVMD 
remains unclear. 
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Adaptive optics (AO) imaging systems enable cellular-resolution 
imaging of the human retina, allowing for direct visualization of cone 
and rod photoreceptor mosaic.30,31 To better understand photoreceptor 
structure across the spectrum of BVMD, we used spectral-domain OCT 
(SD-OCT) and adaptive optics scanning light ophthalmoscopy (AOSLO) 
to assess retinal structure in four members of the same family who are 
at various stages of BVMD and have a known BEST1 mutation. 
Methods 
Four members of a family with a previously identified mutation, 
p.Arg218Cys (c.652C->T) (University of California Ophthalmic 
Molecular Diagnostic Lab, La Jolla, CA), in the BEST1 gene reported to 
be causative mutation in BVMD32 and with clinical findings consistent 
with BVMD participated (Table 1, eFigure 1). The p.Arg218Cys 
mutation is predicted to affect the charge of the bestrophin protein, 
altering its function. Visual acuity was assessed, and a comprehensive 
eye exam including fundus photography was performed for all four 
subjects. Each patient was dilated using one drop of phenylephrine 
(2.5%). Mircoperimerty was performed. Then accommodation was 
suspended using one drop of tropicamide (1%) for subsequent high-
resolution imaging. Axial length was measured using an IOL Master 
(Carl Zeiss Meditec, Dublin, CA). This prospective study was conducted 
in accordance with the tenets of the Declaration of Helsinki and with 
institutional review board approval. 
Subject 
Age, 
y Gender 
Mutation 
in Best1 
gene 
Type of 
Lesion* 
Visual 
Acuity** 
(OD, OS) 
Axial 
Length (OD, 
OS, mm) 
Eye 
imaged 
with 
AOSLO 
IV-3 16 M 
Arg218Cys 
(c.652C-
>T) 
Early 
vitelliform 
20/20, 
20/20 
22.57/22.14 OS 
IV-2 18 F 
Arg218Cys 
(c.652C-
>T) 
Vitelliform 
with early 
vitelliruptive 
20/20, 
20/20 
22.72/22.62 OS 
III-5 50 F 
Arg218Cys 
(c.652C-
>T) 
Late 
vitelliruptive 
20/30, 
20/100 
22.11/21.98 OD 
III-4 59 F 
Arg218Cys 
(c.652C-
>T) 
Atrophic 
20/200, 
20/50 
23.14/23.69 OS 
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Table 1 Patient Demographics 
*Same lesion type in both eyes, 
**Snellen 
y-years, OD –right, OS –left, M-male, F- female, mm- millimeters 
Macular microperimetry was performed using the Spectral 
OCT/SLO MP system (OPKO instrumentation) after a brief training to 
allow for familiarization of the test. A Polar 3 standardized grid 
composed of 28 points arranged in 3 concentric circles (2.3°, 6.6°, and 
11° in diameter from fovea, 4 points in innermost circle, 12 in middle 
and outer circles) was performed using a Goldman III stimulus, a 
200ms duration and a test strategy 4-2. Results were compared to 
previously published normative data33. 
Volumetric images of the macula were obtained using Cirrus 
HD-OCT (Carl Zeiss Meditec, Dublin, CA). Volumes were nominally 6 
mm × 6 mm and consisted of 128 B-scans (512 A-scans/B-scan). 
Retinal thickness was assessed using the built-in macular analysis 
software (software version 5.0), which is automatically generated by 
calculating the difference between the inner limiting membrane (ILM) 
and RPE boundaries. The software’s “fovea finder” algorithm was used 
to determine the location of the fovea on the line scanning 
ophthalmoscope (LSO) image. Additional high-density line scans (1000 
A-scans/B-scan, 100 repeated B scans) were acquired through the 
foveal center in the study eye of each participant using the Bioptigen 
SD-OCT (Bioptigen, Inc., Research Triangle Park, NC). Line scans were 
registered and averaged to reduce speckle noise in the image using 
previously described techniques,34 and were acquired in both the 
horizontal and vertical direction. All scans shown in the figures are 
from the Bioptigen device. Numerous naming conventions exist in the 
literature for the outer hyperreflective layers in SD-OCT scans, so it is 
important to define the one used here. Shown in Figure 1 is a 
horizontal line scan from a normal control, and a corresponding 
longitudinal reflectivity profile (LRP), showing the identity of the bands 
analyzed.35,36 The innermost band corresponds to the external limiting 
membrane (ELM), the second band corresponds to the inner segment 
ellipsoid (ISe),37 the third band corresponds to the outer segment/RPE 
interface (RPE1), and the fourth band corresponds to the RPE (RPE2). 
The peak-to-peak distance between the ELM and ISe is taken as the 
length of the inner segments (IS), while the peak-to-peak distance 
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between the ISe and RPE1 is taken as the length of the outer 
segments (OS). While these may not correspond precisely to the 
absolute IS or OS length, we utilized these same definitions in an 
extensive previously published normative dataset.36 We examined the 
IS and OS length across the horizontal line scan from each subject, 
sampling the scan at 0.2mm intervals. We excluded the central BVMD-
related lesion from further analysis, similar to a previous report.21 
Images of the photoreceptor mosaic were acquired using a previously 
described AOSLO.30,38 Images were obtained using an Inphenix 775nm 
superluminescent diode 12nm FWHM bandwidth with either a,1.0 or 
1.75 degree square field of view. The fovea and surrounding areas 
affected by pathology were imaged in each patient. Parafoveal images 
(~0.65 degrees from fixation) were acquired by instructing the patient 
to fixate on the corners or edges of the raster, while more eccentric 
images were acquired using an internal fixation target. Intraframe 
distortions within the AOSLO retinal images were corrected as 
previously described.30,39 Registration of frames within a given image 
sequence was performed using a “strip” registration method, in which 
the images were registered by dividing the image of interest into 
strips, aligning each strip to the location in the reference frame that 
maximizes the normalized cross correlation between them.39 Once all 
the frames were registered, the 50 frames with the highest normalized 
cross correlation to the reference frame were averaged, in order to 
generate a final image with an increased signal to noise ratio (SNR). 
 
Figure 1 Assignment of outer retinal bands on SD-OCT. Shown is a horizontal line 
scan through the fovea of a normal subject. The graph on the right is a longitudinal 
reflectivity profile (LRP) acquired at the location of the vertical black arrow above the 
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SD-OCT scan. ELM=external limiting membrane, ISe=inner segment ellipsoid, 
RPE1=outer segment/RPE interface, RPE2=RPE. 
These registered and averaged AOSLO images were then 
montaged using Adobe Photoshop (Adobe Systems, Inc., CA). The 
montage was aligned to the color fundus images and the LSO image 
from the Cirrus HD-CT, which was exported with the location of the 
foveal pit marked. Scaling of the images was done based on the 
expected scale of each image and alignment was done manually 
utilizing blood vessel patterns. Cone density was assessed using 55μm 
× 55μm sampling areas adjacent to the visible lesion in two subjects 
and near the fovea within the active lesion in all four subjects using a 
previously described semi-automated algorithm.40 The distance 
between the sampled area and the foveal pit was measured, enabling 
comparison of density values to previously published normative 
values. 
Results 
Four affected subjects from a family with BVMD with known 
p.Arg218Cys mutation in BEST1 gene participated. (eFigure 1) All 
family members were found to be at different stages of the disease, 
summarized in Table 1. The SD-OCT and AOSLO imaging findings were 
unique to each stage (Figures 2–5).. Macular microperimetry 
performed within a 6 degree radius of the fovea revealed areas of 
subnormal individual point sensitivities in regions corresponding to 
clinical retinal lesions (lower left, Figures 2–5) in all but subject IV-3 
with early vitelliform findings. In patient IV-2, decreased point 
sensitivities were seen both in regions surrounding the vitelliform 
lesion and overlying the lesion itself. 
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Figure 2 Imaging of IV-3, left eye – Early vitelliform findings. Fundus exam 
revealed a focal area of granularity just temporal to the fovea (upper left). SD-OCT 
horizonal and vertical scans show normal retinal lamination but focal increased hyper-
reflectivity in the area of granularity seen clinically (upper right). Macular 
microperimetry showed normal point sensitivities in the central 12 degrees (overlay, 
left lower) Adaptive optics imaging of this location (montage registered lower left, area 
imaged indicated by arrows on SD-OCT upper right) shows focal photoreceptor mosaic 
disruption around the area of hyper-reflectivity on OCT with photoreceptor mosaic 
surrounding this area appearing normal (lower right). 
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Figure 5 Imaging of III-4, left eye - Atrophy and Fibrosis. Fundus exam shows 
central hypopigmentation with focal pigment mottling and trace epiretinal membrane 
(ERM) (upper left). SD-OCT horizontal and vertical scans show a lamellar hole, trace 
ERM and loss of the hyperreflective ISe band (upper right). Macular microperimetry 
revealed subnormal point sensitivities in areas central and temporal to fovea when 
fibrosis and atrophy are present clinically (overlay, left lower). Adaptive optics imaging 
of central fovea (montage registered lower left, area imaged indicated by arrows on 
SD-OCT upper right) reveal patchy areas of retained photoreceptors between areas of 
significant photoreceptor loss (lower right). 
Measurement of IS and OS retinal thickness was performed 
using the SD-OCT horizontal line scan in all four subjects. Shown in 
Figure 6 is the IS and OS thickness profile in areas immediately 
adjacent to clinical visible lesions for all four subjects compared to 
data from a previously published normative group.41 Thickness values 
were not calculated over the visible lesion. All 4 subjects were found to 
have IS and OS thickness values within 2 standard deviations of 
normative data. 
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Figure 6 Assessment of photoreceptor layer thickness in BVMD. Top, plot of inner 
segments (IS) length as a function of retinal location along the horizontal meridian. 
Bottom, outer segment (OS) length as a function of retinal location along the 
horizontal meridian. Black line – normative data from 93 people, average age 25.7 
years with standard deviation (stdev) of 8.2 years. Shaded grey area is + 2 stdev. 
Open squares – subject IV-2, Open circles – subject IV-3, Filled squares – subject III-
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5, Filled circles – subject III-4. Thickness values were not calculated over visible 
lesion(s). 
We sought to further assess photoreceptor structure in the 
retinal area adjacent to the BVMD lesions. In two patients having 
lesions with a clear boundary, we were able to obtain AOSLO 
montages that were large enough to encompass the entire lesion 
(Figure 2, eFigure 2). We assessed cone density just nasal to the 
lesion boundary in both IV-3 and IV-2, and determined that the areas 
sampled were 1 degree from the foveal center. The cone mosaic 
appeared contiguous and cone density was 55,900 cones/mm2 in IV-3 
and 43, 700 cones/mm2 in IV-2. Both values are within the normal 
range for this retinal eccentricity.41 
In the SD-OCT scans of one of the subjects (IV-2) we noticed 
significant hyperreflective material in the outer nuclear layer (ONL). 
This has been previously reported in BVMD,42 and is attributed to the 
physical deformation of the Henle fiber layer by the underlying 
vitelliform lesion. Inspection of the SD-OCT volume revealed the 
strongest signal in the inferior retina, just nasal to the fovea. AOSLO 
images from this same location focused in the inner retina revealed 
thin hyperreflective structures running perpendicular to the nerve fiber 
layer (Figure 7). The anatomical location and orientation is consistent 
with that of Henle fibers, and the diameter of these structures 
(average = 2.76 ± 0.32 μm) is consistent with previous histology 
reports.43 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
JAMA Ophthalmology, Vol. 131, No. 9 (September 2013): pg. 1207-1215. DOI. This article is © American Medical 
Association and permission has been granted for this version to appear in e-Publications@Marquette. American Medical 
Association does not grant permission for this article to be further copied/distributed or hosted elsewhere without the 
express permission from American Medical Association. 
13 
 
 
Figure 7 Visualization of Henle fiber layer in BVMD. Presence of the vitelliform 
lesion has altered the angle of retina structure, allowing for visualization of Henle fiber 
layer on SD-OCT (arrows, top). AOSLO imaging at this same location focused at the 
level of the inner retina revealed thin hyperreflective structures running perpendicular 
to nerve fiber bundles, consistent with known anatomy of Henle fibers (lower). 
Comment 
In our study we used SD-OCT and AOSLO to assess outer retinal 
structure in four members of a single family harboring a previously 
reported BEST1 mutation (p.Arg218Cys). The phenotypes ranged from 
early vitelliform changes to a central atrophic area. Disruption of the 
cone mosaic was evident in the AOSLO images at all stages of BVMD 
presented here, including the patient with the earliest stage of 
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vitelliform clinical findings (Figure 2), suggesting this is an early 
finding in patients with BVMD. The degree of this photoreceptor 
disruption varied by stage of disease, and was often patchy with areas 
of significant photoreceptor disruption surrounded by areas of a 
contiguous photoreceptor mosaic, even in the patient with advanced 
atrophy and fibrosis. (Figure 5) It is important to note that disruption 
of visualization of cone structure on AOSLO does not necessarily mean 
the cone cell has been lost. When comparing SD-OCT and AOSLO 
images from the same location, the AOSLO images allowed for better 
understanding of the degree of retained photoreceptor structure at 
that location. This is illustrated in the patient with late vitelliruptive 
changes (Figure 4). SD-OCT of this individual shows significant 
disruption of the hyperreflective ISe band in the areas of subretinal 
nodules, but the AOSLO images reveal islands of contiguous cone 
mosaic adjacent to areas of significant disruption. 
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Figure 4 Imaging of III-5, right eye – Vitelliruptive. Fundus exam reveals an ovoid 
area of hypopigmentation containing several fibrotic nodules (upper left). SD-OCT 
horizontal and vertical scans show outer retinal atrophy and several focal deposits of 
debris in the subretinal space, some separated by trace subretinal fluid. Patchy 
disruption of the hyperreflective ISe band is evident in some areas (upper right). 
Macular microperimetry revealed subnormal point sensitivities in all areas of central 6 
degrees (overlay, left lower). Adaptive optics imaging of central fovea (montage 
registered lower left, area imaged indicated by arrows on SD-OCT upper right) reveals 
significant photoreceptor mosaic disruption overlying these nodules, but relative 
preservation of the photoreceptor mosaic surrounding these lesions (lower right). 
Previous studies have suggested that loss of photoreceptors in 
BVMD could be widespread and not necessarily confined to the 
clinically apparent lesions, and support for this comes from the fact 
that bestrophin, the RPE membrane protein encoded by the BEST1 
gene, is found throughout the retina in individuals unaffected by 
BVMD.17 Kay et al. recently showed increased photoreceptor thickness 
on SD-OCT in patients with BVMD when compared to normal controls 
within the macular region.21 Based on their findings, they conclude 
that the primary anatomical impact is at the photoreceptor level. 
Certainly, our finding that the photoreceptor mosaic is disrupted in the 
earliest stage of clinical vitelliform findings would be consistent with 
this proposed etiology, but our finding of normal IS and OS thickness 
and normal cone density in retinal areas adjacent to visible lesions 
argues against a diffuse structural deficit in BVMD. One possible 
explanation is that the previous study did not correct the lateral scale 
of their SD-OCT scans for individual differences in axial length, 
meaning that different extents of retina contributed to the analysis in 
each retina. Moreover, since the previous analysis averaged the 
thickness measurements across the scan, it is unclear if the retina was 
indeed uniformly affected or if a small retinal area was severely 
abnormal.21 Nevertheless, while our findings do not support diffuse 
disruption of the cone mosaic outside the lesion, it is possible that 
these cells may not be functioning normally. 
Interestingly, macular microperimetry revealed areas of 
subnormal point sensitivities in areas surrounding the vitelliform lesion 
in subject IV-2. Both SD-OCT and AOSLO showed normal outer retinal 
anatomy within these regions. These reduced point sensitivities may 
be result of eye movements reducing the specificity of registration to 
the fundus. However, it may also be possible that functional loss of 
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vision precedes anatomical outer retinal structural loss. High resolution 
microperimetric assessment using adaptive optics technology has been 
described.44,45 To better understand and correlate functional vision to 
photoreceptor mosaic structure pathology, future studies would benefit 
from AOSLO based microperimetry allowing for functional assessment 
at resolutions on par to those used to assess retinal structure. 
It is becoming appreciated that outer retinal pathology can 
affect the appearance of the overlying retina on SD-OCT. For example, 
presence of a vitelliform lesion, large drusen, or pigment epithelial 
detachment alters the orientation of the fibers of Henle as they 
traverse the lesion, altering their reflectivity on SD-OCT.46,47 We also 
observed this effect in one of our subjects (IV-2), however we also 
observed the presence of fine hyperreflective structures running 
perpendicular to the nerve fiber bundles in the AOSLO images at the 
same retinal location (Figure 7). Their anatomical location, orientation, 
and size are consistent with that of Henle fibers. As seen with SD-OCT, 
this demonstrates that when imaged with AOSLO, outer retinal 
disruptions can alter the appearance of the inner retina, and this 
should be taken into consideration when analyzing such images. 
A potential limitation of the current study is that all four 
subjects have the same genetic mutation in the BEST1 gene. While our 
data reveal a spectrum of clinical and subclinical findings associated 
with this particular mutation, it is not possible to extend our findings 
on the integrity of the cone mosaic to other mutations. Future 
investigations should include high-resolution imaging of other 
individuals with different mutations in BEST1 gene to investigate 
possible genotype-dependent differences in photoreceptor structure. 
In summary, we provide evidence from cellular imaging with 
AOSLO that photoreceptor structure can be retained within active 
BVMD lesions, even in apparently atrophic lesions. This photoreceptor 
structure is capable of supporting rather good visual acuity, as visual 
acuity in the eyes imaged here ranged from 20/20 to 20/50. In 
addition, our SD-OCT and AOSLO data show normal photoreceptor 
structure in retinal areas outside the clinically visible lesion, in contrast 
to previous reports21, but consistent with previous findings with 
AOSLO.48 This may represent a specific feature of the mutation studied 
here, or be due to different imaging and measurement procedures. 
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Regardless, our study highlights the utility of AOSLO imaging in 
directly delineating the degree of retained photoreceptor structure in 
diseases like BVMD. In particular, combining information from SD-OCT 
with that from AOSLO gives a complementary view of outer retinal 
structure and provides a more sensitive approach for measuring 
photoreceptor structure than either alone. 
 
 
Figure 3 Imaging of IV-2, left eye – Vitelliform lesion with early vitelliruptive 
changes. Fundus exam reveals single heterogeneous vitellform lesion centered just 
temporal to fovea (upper left). SD-OCT horizonal and vertical scans show the 
vitelliform lesion contains fluid and debris within the subretinal space. There is patchy 
disruption of the hyperreflective ISe band over the lesion (upper right). Macular 
microperimetry revealed subnormal point sensitivities in areas overlying the vitelliform 
lesion and immediately surrounding it. (overlay, left lower). Adaptive optics imaging of 
the vitelliform lesion and area immediately surrounding this (montage registered lower 
left, area imaged indicated by arrows on SD-OCT upper right) reveals disrupted 
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photoreceptor mosaic over the lesion with normal mosaic seen immediately adjacent 
to the lesion. 
Supplementary Material 
Supp Figure 1 
 
eFigure 1: Pedigree of family with Best Vitelliform Macular Dystrophy caused by 
Arg218Cys (c.652C>T) mutation in BEST1 gene. Individuals marked with “*” were 
imaged in this study. (will be moved from here…) 
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